Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/17/2025

Management of Abnormal Uterine Bleeding in IUD Users

Introduction to IUD-Associated Bleeding

  • For patients with an IUD experiencing abnormal uterine bleeding, estradiol can be used to reset the uterine lining, particularly with levonorgestrel IUDs where hormonal treatment with estrogen (10-20 days) is specifically recommended in guidelines, as stated by the CDC [1]
  • The CDC's Selected Practice Recommendations specifically states that hormonal treatment with estrogen (10-20 days) can be used for LNG-IUD users experiencing unscheduled spotting, light bleeding, or heavy/prolonged bleeding [1, 2]

Diagnosis and Treatment

  • Before using estradiol, ensure abnormal bleeding isn't due to infection, pregnancy, malposition of the IUD, or uterine pathology, such as fibroids or polyps [1]
  • Estradiol treatment typically lasts for 10-20 days, with monitoring for improvement in bleeding pattern and follow-up if bleeding persists, considering alternative contraceptive methods [1]

IUD Considerations

  • Uterine fibroids may increase the risk of IUD expulsion (11% vs 0-3% in women without fibroids) [3]
  • Distorted uterine cavities are contraindicated for IUD use (Category 4) [3]
  • Patients with a history of endometrial hyperplasia may benefit from LNG-IUDs, which can lead to disease regression (Category 1) [3]
  • Patients with uterine fibroids may still use IUDs (Category 2), but be aware of higher expulsion risk [3]

Patient Counseling and Management

  • Inform patients that estradiol treatment is temporary (10-20 days) and that the LNG-IUD itself typically reduces menstrual blood loss over time [1]
  • If bleeding irregularities persist despite treatment and are unacceptable to the patient, consider removing the IUD and counseling on alternative contraceptive methods [1]